Danish Pharmaceutical Novo Nordisk to Pay $25 Million to Resolve Allegations of Off-label Promotion of NovoSeven
/ Published June 10, 2011
Danish Pharmaceutical Novo Nordisk to Pay $25 Million to Resolve Allegations of Off-label Promotion of NovoSeven